Search details
1.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Article
in English
| MEDLINE | ID: mdl-32698790
Results
1 -
1
de 1
1
Next >
>>